NEW YORK, NY / ACCESSWIRE / July 7, 2022 / Benessere Capital Acquisition Corp. (NASDAQ:BENE)(NASDAQ:BENEU)(NASDAQ:BENEW)(NASDAQ:BENER) ("Benessere" or the "Company") today announced the filing of a definitive proxy statement (the "Extension Proxy Statement"), to hold a special meeting of stockholders (the "Special Meeting") to amend the Company's charter (the "Extension Amendment") to extend the date by which the Company has to complete a business combination (the "Extension") from July 7, 2022 to January 7, 2023, or such earlier date as determined by the Company's board of directors (the "Extended Date").

The Special Meeting to approve the Extension Amendment will be held virtually on July 7, 2022 at 12:00 PM, Eastern Time and can be accessed by visiting https://www.cstproxy.com/benespac/sm2022.

The Company's stockholders of record at the close of business on the record date, June 3, 2022, are entitled to vote the shares of common stock of Benessere owned by them at the Special Meeting. Every stockholder's vote is important, regardless of the number of shares held, and the Company requests the prompt submission of votes.

If stockholders have any questions or need assistance with voting, please call the Company's proxy solicitor, Advantage Proxy, at 1-877-870-8565 (toll free) or by email at ksmith@advantageproxy.com.

If the Extension Amendment is approved and the Extension is implemented, the Company's sponsor will contribute to the Company's trust account an aggregate amount equal to $0.033 per share of Class A common stock issued in the Company's initial public offering that is not redeemed in connection with the stockholder vote to approve the Extension Amendment, for each calendar month (commencing on July 7, 2022 and on the 7th day of each subsequent month) until the Extended Date, or portion thereof. Such contributions will be made as a loan that will not accrue interest and will be repayable to the sponsor or its designee upon the consummation of an initial business combination. The Contribution will increase the pro rata portion of the funds available in the Company's trust account in the event of the consummation of an initial business combination or liquidation from approximately $10.35 per share to up to approximately $10.55 per share.

About Benessere

Benessere is a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. Benessere's strategy is to identify and complete business combinations with technology-focused middle market and emerging growth companies in North, Central and South America. For more information, please visit www.benespac.com.

Additional Information and Where to Find It

Benessere urges investors, stockholders and other interested persons to read the definitive proxy statement dated July 6, 2022 (the "Extension Proxy Statement"), as well as other documents filed by Benessere with the Securities and Exchange Commission (the "SEC"), because these documents contain important information about Benessere and the Extension. The Extension Proxy Statement was also mailed to stockholders of Benessere as of a record date of June 3, 2022, on or about July 7, 2022. Shareholders may obtain copies of the Extension Proxy Statement, without charge, at the SEC's website at www.sec.gov or by directing a request to: info@benespac.com.

Participants in Solicitation

Benessere and its directors, executive officers and other members of their management and employees may be deemed to be participants in the solicitation of proxies of Benessere stockholders in connection with the Extension. Investors and security holders may obtain more detailed information regarding the names, affiliations and interests of Benessere's directors and officers in the Extension Proxy Statement, which may be obtained free of charge from the sources indicated above.

Non-Solicitation

This press release is not a proxy statement or solicitation of a proxy, consent or authorization with respect to any securities or in respect of the Extension and shall not constitute an offer to sell or a solicitation of an offer to buy the securities of Benessere, nor shall there be any sale of any such securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of such state or jurisdiction. No offer of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended.

Forward Looking Statements

This press release includes forward-looking statements that involve risks and uncertainties. Forward-looking statements are statements that are not historical facts. Such forward-looking statements are subject to risks and uncertainties, which could cause actual results to differ from the forward-looking statements. These forward-looking statements and factors that may cause such differences include, without limitation, uncertainties relating to Benessere's shareholder approval of the Extension, Benessere's inability to complete an initial business combination within the required time period or, and other risks and uncertainties indicated from time to time in filings with the SEC, including Benessere's Annual Report on Form 10-K for the fiscal year ended December 31, 2021 under the heading "Risk Factors" and other documents Benessere has filed, or to be filed, with the SEC. Readers are cautioned not to place undue reliance upon any forward-looking statements, which speak only as of the date made. Benessere expressly disclaims any obligations or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in Benessere's expectations with respect thereto or any change in events, conditions or circumstances on which any statement is based.

SOURCE: Benessere Capital Acquisition Corp